COVID-19 vaccine maker AstraZeneca says revenue in first quarter reaches US$275 million

Published Apr 30 2021 at 7:00 AM GMT
  • AstraZeneca said on Friday (Apr 30) its COVID-19 vaccine contributed US$275 million in sales and shaved off three cents per share from its first-quarter earnings, as the drug maker reported better-than-expected results and forecast sales growth.
  • This is the first time the drug maker has given.


  • Published Apr 30, 2021 7:00 AM GMT